Recent publications on Cancer

Bowles EJ, Sickles EA, Miglioretti DL, Carney PA, Elmore JG. Recommendation for short-interval follow-up examinations after a probably benign assessment: is clinical practice consistent with BI-RADS guidance?  AJR Am J Roentgenol. 2010;194(4):1152-9. PubMed

Yao S, Barlow WE, Albain KS, Choi JY, Zhao H, Livingston RB, Davis W, Rae JM, Yeh IT, Hutchins LF, Ravdin PM, Martino S, Lyss AP, Kent Osborne C, Abeloff MD, Hortobagyi GN, Hayes DF, Ambrosone CB. Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer.  Breast Cancer Res Treat. 2010 Nov;124(2):433-9. Epub 2010 Mar 23. PubMed

Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to antidepressant medication use.  Int J Cancer. 2011 Jan 1;128(1):227-32. Epub 2010 Mar 15. doi: 10.1002/ijc.25322. PubMed

Newcomb PA, Wernli KJ Risk factors. In Breast Cancer Risk Reduction and Early Detection Strategies. Edited by E. Sauter and M. Daly. Springer. New York City, 2010, pages 3-22. PubMed

Kapp JM, Walker R, Haneuse S, Buist DS, Yankaskas BC. Are there racial/ethnic disparities among women younger than 40 undergoing mammography?  Breast Cancer Res Treat. 2010 Nov;124(1):213-22. Epub 2010 Mar 4. PubMed

Ludman EJ, Ichikawa LE, Simon GE, Rohde P, Arterburn D, Operskalski BH, Linde JA, Jeffery RW. Breast and cervical cancer screening specific effects of depression and obesity.  Am J Prev Med. 2010;38(3):303-10. PubMed

Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Li D, Mandelson MT, Olson SH, Risch HA, Zheng W, Albanes D, Bamlet WR, Berg CD, Boutron-Ruault MC, Buring JE, Bracci PM, Canzian F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hassan M, Howard B, Hunter DJ, Hutchinson A, Jenab M, Kaaks R, Kooperberg C, Krogh V, Kurtz RC, Lynch SM, McWilliams RR, Mendelsohn JB, Michaud DS, Parikh H, Patel AV, Peeters PH, Rajkovic A, Riboli E, Rodriguez L, Seminara D, Shu XO, Thomas G, Tjønneland A, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wang Z, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Fraumeni JF Jr, Hoover RN, Hartge P, Chanock SJ. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.  Nat Genet. 2010;42(3):224-8. Epub 2010 Jan 24. PubMed

Taira AV, Merrick GS, Galbreath RW, Butler WM, Lief JH, Wallner KE. Relationship between prostate cancer mortality and number of unfavourable risk factors in men treated with definitive brachytherapy.  BJU Int. 2010 Sep;106(6):809-14. Epub 2010 Mar 1. PubMed

Cook AJ, Onega TL, Shui X, Kirlin BA, Buist D. PS2-36: influence of travel time on the receipt of surveillance mammograms for women with history of breast cancer. Clin Med Res. 2010 March; 8(1): 35. PubMed

Mahajan K, Coppola D, Challa S, Fang B, Chen YA, Zhu W, Lopez AS, Koomen J, Engelman RW, Rivera C, Muraoka-Cook RS, Cheng JQ, Schönbrunn E, Sebti SM, Earp HS, Mahajan NP. Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation. PLoS One. 2010 Mar 19;5(3):e9646. PubMed

Harigopal M, Barlow WE, Tedeschi G, Porter PL, Yeh IT, Haskell C, Livingston R, Hortobagyi GN, Sledge G, Shapiro C, Ingle JN, Rimm DL, Hayes DF. Multiplexed assessment of the Southwest Oncology Group-directed intergroup breast cancer trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome. Am J Pathol. 2010;176(4):1639-47. Epub 2010 Feb 11. PubMed

Allen JD, Barlow WE, Duncan RP, Egede LE, Friedman LS, Keating NL, Kim P, Lave JR, Laveist TA, Ness RB, Optican RJ, Steinwachs D, Virnig BA. NIH State-of-the-Science Conference statement: enhancing use and quality of colorectal cancer screening. NIH Consens State Sci Statements. 2010;27(1). PubMed

Fagerlin A, Zikmund-Fisher BJ, Smith DM, Nair V, Derry HA, McClure JB, Greene S, Stark A, Alford SH, Lantz P, Hayes DF, Wiese C, Zweig SC, Pitsch R, Jankovic A, Ubel PA. Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.  Breast Cancer Res Treat. 2010 Feb;119(3):613-20. Epub 2009 Nov 12. PubMed

Yong M, Schwartz SM, Atkinson C, Makar KW, Thomas SS, Newton KM, Aiello Bowles EJ, Holt VL, Leisenring WM, Lampe JW. Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States.  Cancer Epidemiol Biomarkers Prev. 2010;19(2):537-46. PubMed

Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Anderson G, Boutron-Ruault MC, Buring JE, Canzian F, Chanock SJ, Clipp S, Gaziano JM, Giovannucci EL, Hallmans G, Hankinson SE, Hoover RN, Hunter DJ, Hutchinson A, Jacobs K, Kooperberg C, Lynch SM, Mendelsohn JB, Michaud DS, Overvad K, Patel AV, Rajkovic A, Sanchéz MJ, Shu XO, Slimani N, Thomas G, Tobias GS, Trichopoulos D, Vineis P, Virtamo J, Wactawski-Wende J, Yu K, Zeleniuch-Jacquotte A, Hartge P, Fuchs CS. Pancreatic cancer risk and ABO blood group alleles: results from the Pancreatic Cancer Cohort Consortium. Cancer Res. 2010;70(3):1015-23. Epub 2010 Jan 26. PubMed

Wernli KJ, Aiello Bowles EJ, Haneuse S, Elmore JG, Buist DS. Timing of follow-up after abnormal screening and diagnostic mammograms. Am J Manag Care. 2011 Feb;17(2):162-7. PubMed

Jensen A, Geller BM, Gard CC, Miglioretti DL, Yankaskas B, Carney PA, Rosenberg RD, Vejborg I, Lynge E. Performance of diagnostic mammography differs in the United States and Denmark.  Int J Cancer. 2010 Oct 15;127(8):1905-12. Epub 2010 Jan 26. PubMed

Jacobs EJ, Chanock SJ, Fuchs CS, LaCroix A, McWilliams RR, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Bas Bueno-de-Mesquita H, Gross M, Helzlsouer K, Petersen G, Zheng W, Agalliu I, Allen NE, Amundadottir L, Boutron-Ruault MC, Buring JE, Canzian F, Clipp S, Dorronsoro M, Gaziano JM, Giovannucci EL, Hankinson SE, Hartge P, Hoover RN, Hunter DJ, Jacobs KB, Jenab M, Kraft P, Kooperberg C, Lynch SM, Sund M, Mendelsohn JB, Mouw T, Newton CC, Overvad K, Palli D, Peeters PH, Rajkovic A, Shu XO, Thomas G, Tobias GS, Trichopoulos D, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu K, Zeleniuch-Jacquotte A. Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PANSCAN). Int J Cancer. 2010 Sep 1;127(6):1421-8. Epub 2010 Jan 4. PubMed

Klasnja P, Hartzler AC, Unruh KT, Pratt W. Blowing in the wind: unanchored patient information work during cancer care. In Proceedings of the ACM SIGCHI Conference on Human Factors in Computing Systems CHI’10 (CHI Conf Proc). 2010: 193-202. PubMed

Albain KS, Barlow WE, Ravdin PM, Farrar WB, Burton GV, Ketchel SJ, Cobau CD, Levine EG, Ingle JN, Pritchard KI, Lichter AS, Schneider DJ, Abeloff MD, Henderson IC, Muss HB, Green SJ, Lew D, Livingston RB, Martino S, Osborne CK. Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.  Lancet. 2009;374(9707):2055-63. Epub 2009 Dec 10. PubMed